UB Paderborn / Katalog / Suche / in CDI

SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues

Immune Network, 2021, 21(6), , pp.1-8

2021

Volltextzugriff (PDF)

Novel Enhanced Mammalian Cell Transient Expression Vector via Promoter Combination

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2330

2024

Volltextzugriff (PDF)

Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022

Journal of Korean Medical Science, 2024, 39(5), , pp.1-13

2024

Volltextzugriff (PDF)

Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey

Epidemiology and Health, 2022, 44(0), , pp.1-6

2022

Volltextzugriff (PDF)

COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19

Frontiers in immunology, 2022-09, Vol.13, p.975363-975363

2022

Volltextzugriff (PDF)

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

Frontiers in immunology, 2024-05, Vol.15, p.1385135-1385135

2024

Volltextzugriff (PDF)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules

Frontiers in cellular and infection microbiology, 2022-07, Vol.12, p.948014

2022

Volltextzugriff (PDF)

Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity

Frontiers in immunology, 2023-01, Vol.13, p.1035441-1035441

2023

Volltextzugriff (PDF)

Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device

International journal of infectious diseases, 2023-03, Vol.128, p.112-120

2023

Volltextzugriff (PDF)

Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea

Frontiers in immunology, 2023-12, Vol.14, p.1306604-1306604

2023

Volltextzugriff (PDF)

Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022

Microbiology spectrum, 2023-10, Vol.11 (5), p.e0165523-e0165523

2023

Volltextzugriff (PDF)

Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study

Journal of Korean Medical Science, 2022, 37(27), , pp.1-9

2022

Volltextzugriff (PDF)

Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain

Microbiology spectrum, 2022-12, Vol.10 (6), p.e0266922-e0266922

2022

Volltextzugriff (PDF)

Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy

Heliyon, 2024-03, Vol.10 (5), p.e27211-e27211, Article e27211

2024

Volltextzugriff (PDF)

Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea

Epidemiology and health, 2022-09, Vol.44, p.e2022085-e2022085

2022

Volltextzugriff (PDF)

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

Vaccines (Basel), 2023-01, Vol.11 (1), p.120

2023

Volltextzugriff (PDF)

Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination

The Journal of infection, 2022-11, Vol.85 (5), p.573-607

2022

Volltextzugriff (PDF)

Heterologous ChAdOx1 and BNT162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity

Clinical microbiology and infection, 2022-10, Vol.28 (10), p.1390-1390.e7

2022

Volltextzugriff (PDF)

Retrospective analysis of the results of acellular pertussis vaccine toxicity tests performed in Korea

Human vaccines & immunotherapeutics, 2012-06, Vol.8 (6), p.783-787

2012

Volltextzugriff (PDF)

Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference

Clinical microbiology and infection, 2024-05, Vol.30 (5), p.653-659

2024

Volltextzugriff (PDF)

Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity

Journal of medical virology, 2023-12, Vol.95 (12), p.e29285-n/a

2023

Volltextzugriff (PDF)

Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS‐CoV‐2 Omicron BA.1 and BA.5 variants

Journal of medical virology, 2023-12, Vol.95 (12), p.e29329-n/a

2023

Volltextzugriff (PDF)

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals

The Journal of infection, 2023-02, Vol.86 (2), p.e46-e48

2023

Volltextzugriff (PDF)

Effects of Air Transportation Cause Physiological and Biochemical Changes Indicative of Stress Leading to Regulation of Chaperone Expression Levels and Corticosterone Concentration

Experimental Animals, 2009, Vol.58(1), pp.11-17

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues

Novel Enhanced Mammalian Cell Transient Expression Vector via Promoter Combination

Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022

Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey

COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules

Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity

Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device

Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea

Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022

Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study

Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain

Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy

Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination

Heterologous ChAdOx1 and BNT162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity

Retrospective analysis of the results of acellular pertussis vaccine toxicity tests performed in Korea

Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference

Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity

Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS‐CoV‐2 Omicron BA.1 and BA.5 variants

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals

Effects of Air Transportation Cause Physiological and Biochemical Changes Indicative of Stress Leading to Regulation of Chaperone Expression Levels and Corticosterone Concentration

Suchergebnisse filtern